Brinker Capital Investments, LLC Organon & Co. Transaction History

Brinker Capital Investments, LLC

$11.4 Billion
Q3 2025

A detailed history of Brinker Capital Investments, LLC transactions in Organon & Co. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 76,778 shares of OGN stock, worth $578,138. This represents 0.01% of its overall portfolio holdings.

Number of Shares

76,778

Previous 63,509 20.89%

Holding current value

$578,138

Previous $614,000 33.39%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$8.4 - $10.85 $111,459 - $143,968	13,269 Added 20.89%	76,778 $819,000
Q2 2025 Aug 27, 2025	BUY	$8.04 - $14.72 $273,199 - $500,185	33,980 Added 115.07%	63,509 $614,000
Q2 2025 Aug 14, 2025	SELL	$8.04 - $14.72 $22,431 - $41,068	-2,790 Reduced 8.63%	29,529 $285,000
Q1 2025 Jul 31, 2025	SELL	$14.29 - $16.41 $52,958 - $60,815	-3,706 Reduced 10.29%	32,319 $481,000
Q4 2024 Jul 31, 2025	BUY	$14.44 - $18.83 $366,270 - $477,622	25,365 Added 237.95%	36,025 $537,000

Q3 2024 Jul 31, 2025	SELL	$18.65 - $23.03 $373,186 - $460,830	-20,010 Reduced 65.24%	10,660 $203,000
Q2 2024 Jul 31, 2025	BUY	$17.45 - $21.96 $251,384 - $316,355	14,406 Added 88.58%	30,670 $634,000
Q1 2024 Jul 31, 2025	BUY	$13.78 - $18.8 $6,325 - $8,629	459 Added 2.9%	16,264 $305,000
Q4 2023 Jul 31, 2025	SELL	$10.95 - $17.32 $851,877 - $1.35 Million	-77,797 Reduced 83.11%	15,805 $227,000
Q3 2023 Jul 31, 2025	BUY	$16.59 - $23.77 $1.18 Million - $1.69 Million	70,925 Added 312.76%	93,602 $1.62 Million
Q2 2023 Jul 31, 2025	SELL	$19.27 - $24.63 $1.24 Million - $1.58 Million	-64,261 Reduced 73.92%	22,677 $471,000
Q1 2023 Jul 31, 2025	BUY	$21.42 - $32.08 $19,470 - $29,160	909 Added 1.06%	86,938 $2.04 Million
Q4 2022 Feb 06, 2023	BUY	$23.31 - $28.61 $1.69 Million - $2.07 Million	72,457 Added 533.87%	86,029 $2.4 Million
Q3 2022 Nov 01, 2022	BUY	$23.4 - $34.25 $84,965 - $124,361	3,631 Added 36.53%	13,572 $318,000
Q2 2022 Jul 18, 2022	SELL	$31.66 - $38.9 $21,908 - $26,918	-692 Reduced 6.51%	9,941 $335,000
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $51,643 - $66,754	1,696 Added 18.98%	10,633 $371,000
Q4 2021 Feb 08, 2022	SELL	$28.67 - $37.13 $2,207 - $2,859	-77 Reduced 0.85%	8,937 $272,000
Q2 2021 Aug 03, 2021	BUY	$28.45 - $38.0 $256,448 - $342,532	9,014 New	9,014 $273,000

Others Institutions Holding OGN

# of Institutions

790

Shares Held

197M

Call Options Held

2.5M

Put Options Held

2.94M

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $1.92B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Account

Brinker Capital Investments, LLC Organon & Co. Transaction History